LATEST ALERTS
The launch of many CBD-containing foods, beverages and cosmetics in California has been delayed further as a bill legalising their sale is now not expected to pass before the end of the legislative session, which ends on on 13th September
Curaleaf, a US-based vendor of CBD products with a presence in 12 states, has responded to warnings made by the FDA about its marketing of CBD products
The US Drug Enforcement Agency has decided to expand cannabinoid scientific research and no longer requires registration for the growth or research of hemp
Despite continuing uncertainty, the Russian CBD market is on the verge of big changes, following the approval of a draft bill by the national parliament
A hemp licence is required to possess or grow “rooted hemp” in the US state of Tennessee, and import and export is generally allowed subject to meeting requirements
Virginian law differentiates between dealer, grower, processor, and a person who buys industrial hemp for personal use or retail sale in the state – all of which is legal in Virginia
Americans for Safe Access has issued the Patient’s Guide to CBD, Ireland sees increase in hemping-growing licence applications, and over 6000 plants have been seized in Portugal
Our latest updates on the regulations regarding South Carolina’s laws around growing, processing and import and export of CBD products can be found here
CBD end-products with no more than 0.3% THC are within the regulations of the law in Georgia, providing they are not added to foodstuff. This report provides details
The panel largely responsible for recommending which drugs the UK’s National Health Service (NHS) should provide may discourage use of the CBD-based drug Epidyolex
State regulations for Connecticut relating to permits, processing, import and export of CBD products are outlined here
Hemp products not exceeding the federal limit of 0.3% THC content are explicitly legal in New Jersey. This report provides details
Pennsylvania is one of the US states that has implemented the 2018 federal Farm Bill, and distinguishes between industrial hemp and marijuana
Our latest look at the regulations governing CBD in Greece details what can be grown, what products are allowed on the market and what further regulations are proposed
Austrian and German police policy, local THC decision in Italy, Slovakian de-scheduling, Croatian proposals, US federal and state rulings and Israeli priorities come under the regulatory spotlight
A new government decree in Colombia is expected to boost the hemp/cannabis export market by as early as the end of 2019, leading to optimism about the industry in the country
CBD and industrial hemp are quite tightly regulated in New York State, as detailed in this short regulatory report
In our latest look at the rules and regulations governing CBD in England, Wales and Scotland, we look at what can and can’t be produced or sold and what licences are required
Some Italian companies have begun to register CBD hemp flower products as animal feed in an attempt to avoid regulatory confusion and uneven enforcement in the country
Under Slovak law, CBD is classed as a psychotropic substance and as such it cannot be extracted, stored, or used for manufacture of final products without authorisation under the Narcotics Act
The future of one of Canada’s largest cannabis companies is hanging in the balance after a whistleblower and an unannounced inspection by Health Canada triggered a series of problems for CannTrust
CBD supplier Kannaway says it has been granted licences confirming compliance with the law and permitting free sale of a product in an EU member state – Bulgaria – as well as in Russia
The precise role Mexico’s government should play in a future cannabis industry was among the major issues discussed at a recent three-day event hosted by the country’s Senate
CBD-Intel’s regular round-up of regulatory news features items from the US, Mexico, Germany, Italy, Spain, Thailand, Trinidad and Tobago, and the self-governing UK dependency of Jersey
The UK’s largest high street health food retailer is increasing the number of CBD products it sells with a new range – and with it testing the rules on health claims
Hemp can now be grown on the Channel Island of Jersey following the issuance of the first licence to harvest, process and store hemp flower in preparation for CBD extraction.
CBD vaping stakeholders in Europe expect to see the category continue to grow – fuelled by unclear regulations over CBD as a food ingredient combined with a low barrier to entry
CBD-Intel’s regular round-up of regulatory news features items from Portugal, the UK, Germany, Italy, Denmark, North America, Mexico, Colombia and Zimbabwe
Japanese law is easygoing on some aspects of the CBD market and very strict on others, as a result of the country’s rigorous regulation of cannabis
CBD-Intel’s regular round-up of regulatory news features items from Germany, Italy, France, the Netherlands, Spain, Luxembourg, Canada, the US and South Africa
A UK hemp farming co-operative has told CBD-Intel of its plans to launch a campaign to raise support for legislative changes to support the UK CBD industry
This report examines the somewhat ambiguous legal position of hemp and CBD products in Chile, where there is no clear legislative regime for CBD, and where isolated CBD is not a scheduled substance
A British shop specialising in hemp-related products says it has been told to remove some information from its website by the organisation responsible for regulating medicinal health claims.
A European review committee has recommended that British company GW Pharmaceuticals’ Epidyolex (known as Epidiolex in the US) be licensed as a medicine in the European Union.
In our latest regulatory snapshot, we look at the current situation in Italy — where taxes and rules have been changing regularly over recent times
CBD-Intel’s report on the regulatory status of CBD in China provides all you need to know about the present legal status of CBD, plus hemp cultivation and much more
CBD-Intel’s regular round-up of regulatory news features items from Canada, New York, Texas, Nevada, Washington State, Italy and Portugal
A batch of CBD oil has been removed from sale by authorities in the Republic of Ireland after it was found to contain THC
The US FDA has issued a warning to Curaleaf, which it says is selling CBD products with improper claims to treat diseases like cancer, withdrawal from opioids, pain, and anxiety
Many US senators seem ready to pass a law allowing financial institutions to work with CBD businesses. That’s if a hearing on the SAFE Banking Act is any indication
The Polish CBD sector is beset by confusing regulation and uneven enforcement – but it does benefit from a reduced rate of VAT, below even that of prescription medical cannabis
The US Food and Drug Administration (FDA)’s request for comments on regulating cannabis-related products drew 4492 responses covering a dizzying array of views
CBD-Intel brings you regulatory updates and snippets from the US, UK, Italy, Germany and Belgium
Sales of water infused with CBD may be held back by doubts over whether the product is effective and also by regulation, recent reporting by CBD-Intel suggests
A tough regulatory regime in Serbia may soon become even tougher as the Commission for Psychoactive Controlled Substances believes CBD should be a scheduled substance
Health Canada has revoked the licence of producer Agrima Botanicals and put a hold on product grown by CannTrust
CBD-Intel’s regular round-up of regulatory snippets features news from the US, Europe and China
While the US FDA looks at paths for providing CBD research and routes to market, Congress may have a further opportunity to encourage legal developments in that direction
Italy’s Supreme Court has published the reasoning behind its ruling that cannabis products are illegal except for those without psychotropic effects – without adding any clarity
From hummus to suppositories, the UK CBD market is highly fragmented, with over 700 brands available, as CBD-Intel managing director Tim Phillips explains in this presentation given at the Europe CBD Expo in London
Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.
"*" indicates required fields
Notifications
